Safety and Effectiveness of Ultrasound-Guided Artificial Ascites-Assisted Puncture and Sclerotherapy for Ovarian Cysts

Background Ovarian cysts are a common gynecological condition that can cause significant morbidity. Ultrasound-guided sclerotherapy is a minimally invasive treatment option. This study aims to assess the safety and effectiveness of ultrasound-guided artificial ascites-assisted puncture and sclerotherapy for ovarian cysts. Methods A retrospective analysis was conducted on 100 ovarian cyst patients treated from January 2019 to June 2023 at Zhejiang Rongjun Hospital. Patients were divided into observation (44 cases) and control (56 cases) groups based on the use of artificial ascites. The primary endpoints included the incidence of pain and vagal reflex during and after surgery, and the cure rate and effective rate of sclerotherapy assessed by ultrasound at 3, 6, and 12 months post-treatment. Results The observation group experienced significantly lower rates of pain (11.36%) and vagal reflexes (4.55%) compared to the control group (35.71% and 25.00% respectively, P < 0.01). The cure rate was 93.18% in the observation group and 82.14% in the control group (P < 0.05). The effective rate was 100% in the observation group, while it was 91.07% in the control group (P < 0.05). No post-operative infections were observed in either group. Conclusion Ultrasound-guided artificial ascites-assisted puncture and sclerotherapy significantly enhances the safety and efficacy of sclerotherapy for ovarian cysts, reducing complications during and after the procedure. It is recommended for widespread clinical use.